$ACRX I think I’m going to change my strategy on this one. It was a bad buy but I do feel bullish on it regardless. I was buying amounts consistently regardless of price between $1-2. I should have bought more at its $0.70’s low. Now instead I’m going to triple my position if below $1.15. It seems to consistently stay between $1.30-1.50 which assures me that I can make a profit. I was long but the chances of success become smaller everyday. It’s pharmaceutical is too specialized and the company has been bugged by so many problems even before COVID19. It’s estimated break even point ist until the end of 2021 and I think the company might run out of cash by then. Since BE isn’t for another year and a half, I’d rather play it safe and just watch it closely.
  • 2